{"anticipatedPostingDate":"2027-12","denomUnitsSelected":"Participants","description":"TTR was defined, for participants with an objective response per IMWG criteria, as the time from the date of first dose to the first documentation of objective response that was subsequently confirmed.","reportingStatus":"NOT_POSTED","timeFrame":"From date of first dose until confirmed disease progression, death, start of new anticancer therapy, whichever occurred first (up to approximately 20.14 months)","title":"Time-to-Response (TTR) as Per IMWG Criteria by Investigator Assessment","type":"SECONDARY"}